Abbvie Inc
NYSE:ABBV
Abbvie Inc
Total Other Income
Abbvie Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
$-4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$258m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
$-15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
$-20m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-58%
|
|
Seagen Inc
NASDAQ:SGEN
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Total Other Income?
Total Other Income
-4.7B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Other Income amounts to -4.7B USD.
What is Abbvie Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
-204%
Over the last year, the Total Other Income growth was -91%. The average annual Total Other Income growth rates for Abbvie Inc have been 6% over the past three years , -204% over the past five years .